SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No.     )*

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

2

3

4

Item 1.

(a)                                 Name of Issuer:

Corvus Pharmaceuticals, Inc. (“Corvus” or the “Company”)

(b)                                 Address of Issuer’s Principal Executive Offices:

863 Mitten Road
Suite 102
Burlingame, CA  94010

Item 2.

(a)                                 Name of Persons Filing:

Richard A. Miller (“Dr. Miller”)
Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the “Miller-Horning Trust”)
Sandra J. Horning (“Dr. Horning”)

(b)                                 Address of Principal Business Office:

The principal business office for all persons filing is:

c/o Corvus Pharmaceuticals, Inc.
863 Mitten Road
Suite 102
Burlingame, CA  94010

(c)                                  Citizenship:

Richard A. Miller is a U.S. citizen.  The Miller-Horning Trust is organized under the laws of the State of California.  Sandra J. Horning is a U.S. citizen.

(d)                                 Title of Class of Securities:

Common Stock, $0.0001 par value per share

(e)                                  CUSIP Number:

221015 10 0

Item 3.                                                         If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

Not applicable.

5

Item 4.                                                         Ownership.

(a)                                 Amount Beneficially Owned:

All shares owned by the Miller-Horning Trust may be deemed to be beneficially owned by Richard A. Miller and/or Sandra J. Horning.

(b)                                 Percent of Class:

All percentages are calculated using a denominator of 20,406,856 outstanding shares as of March 29, 2016 (the closing date of the Company’s initial public offering). Dr. Miller’s beneficial ownership includes 20,833 shares that could be acquired within 60 days of March 29, 2016.

(c)                                  Number of shares as to which such person has:

(i)                                     Sole power to vote or direct the vote:

(ii)                                  Shared power to vote or direct the vote:

(iii)                               Sole power to dispose or direct the disposition of:

(iv)                              Shared power to dispose or direct the disposition of:

* Dr. Miller and Dr. Horning may be deemed to have shared power to vote, or direct the vote of, and shared power to dispose of, or direct the disposition of, shares held by the Miller-Horning Trust.

Item 5.                                                         Ownership of Five Percent or Less of a Class.

Not Applicable.

6

Item 6.                                                         Ownership of More than Five Percent on Behalf of Another Person.

Not Applicable.

Item 7.                                                         Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

Not Applicable.

Item 8.                                                         Identification and Classification of Members of the Group.

See Item 2.  The filing persons are making a joint filing pursuant to Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.  The filing parties have executed an Agreement with Respect to Joint Filing of Schedule 13G, which is filed as Exhibit 1 to this Schedule 13G.

Item 9.                                                         Notice of Dissolution of Group.

Not Applicable.

Item 10.                                                  Certification.

Not Applicable.

7

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

On behalf of the following filing persons:

Richard A. Miller
Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985
Sandra J. H orning

8

Exhibit 1

The undersigned hereby agree that any statement on Schedule 13G to be filed with the Securities and Exchange Commission by any of the undersigned, including any amendments thereto, with respect to the securities of Corvus Pharmaceuticals, Inc. may be filed by any of the undersigned as a joint filing on behalf of all of the undersigned.

9